AI assistant
Sending…
PMV Pharmaceuticals, Inc. — Director's Dealing 2022
Feb 8, 2022
34350_dirs_2022-02-08_de53b8ab-30f6-4294-b86d-fc61682a31af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2021-12-30
Reporting Person: Kung Winston (COO, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-30 | Common Stock | G | 2725 | $0.00 | Disposed | 6600 | Direct |
Footnotes
F1: The reported shares were acquired under the Issuer's stock purchase plan on May 20, 2021.
More from PMV Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 9
Interim / Quarterly Report
2025
Nov 12
Regulatory Filings
2025
Nov 12
Major Shareholding Notification
2025
Nov 12
Director's Dealing
2025
Oct 29